Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06095531 · ClinicalTrials.gov registry record · NA

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

A NA study of Craniotomy, sponsored by RevBio.

Active
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06095531 is a NA study of Craniotomy that is active but no longer recruiting, run by RevBio. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06095531, a NA study of Craniotomy, is active but no longer recruiting, sponsored by RevBio.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

This clinical pilot study will evaluate the use of a bioresorbable bone adhesive to improve cranial flap fixation at two study time points (at the time of fixation and 6 months). The aim of this Pilot Study is to demonstrate the safety and efficacy of the use of Tetranite for Cranial Flap Fixation (TN-CFF) to allow clinical study of the TN-CFF device in a greater number of patients.

Conditions Studied

Interventions

  • DEVICE Tetranite for Cranial Flap Fixation (TN-CFF)

Study Locations (2)

Massachusetts

  • Brigham and Women's Hospital - Boston

Tennessee

  • Semmes Murphey Clinic - Memphis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-04-18
Est. Completion 2026-06-30
Phase NA

Sponsor

RevBio

2 total trials

What the Registry Record Tells You About NCT06095531

The ClinicalTrials.gov registry entry for NCT06095531 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RevBio, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Craniotomy appearing as the primary indexed condition, and to 1 intervention - of which Tetranite for Cranial Flap Fixation (TN-CFF) is the first listed.

NCT06095531 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06095531 about?

NCT06095531 is a clinical study titled "A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive". This clinical pilot study will evaluate the use of a bioresorbable bone adhesive to improve cranial flap fixation at two study time points (at the time of fixation and 6 months). The aim of this Pilot Study is to demonstrate the safety and efficacy of the use of Tetranite for Cranial Flap Fixation (...

What is the current status of trial NCT06095531?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-04-18. Estimated completion is 2026-06-30.

What conditions does trial NCT06095531 study?

This clinical trial studies the following conditions: Craniotomy.

What interventions are being tested in trial NCT06095531?

The interventions under investigation include: Tetranite for Cranial Flap Fixation (TN-CFF) (DEVICE).

Who is sponsoring clinical trial NCT06095531?

This trial is sponsored by RevBio, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06095531 being conducted?

This trial has 2 study locations across Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Craniotomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.